Exportação concluída — 

Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate

Bibliographic Details
Main Author: Fraqueza, Gil
Publication Date: 2019
Other Authors: Fuentes, Juan, Krivosudský, Lukáš, Dutta, Saikat, Mal, Sib Sankar, Roller, Alexander, Giester, Gerald, Rompel, Annette, Aureliano, Manuel
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.1/12656
Summary: Polyoxometalates (POMs) are promising inorganic inhibitors for P-type ATPases. The experimental models used to study the effects of POMs on these ATPases are usually in vitro models using vesicles from several membrane sources. Very recently, some polyoxotungstates, such as the Dawson anion [P2W18O62]6-, were shown to be potent P-type ATPase inhibitors; being active in vitro as well as in ex-vivo. In the present study we broaden the spectrum of highly active inhibitors of Na+/K+-ATPase from basal membrane of epithelial skin to the bi-capped Keggin-type anion phosphotetradecavanadate Cs5.6H3.4PV14O42 (PV14) and we confront the data with activity of other commonly encountered polyoxovanadates, decavanadate (V10) and monovanadate (V1). The X-ray crystal structure of PV14 was solved and contains two trans-bicapped α-Keggin anions HxPV14O42(9-x)-. The anion is built up from the classical Keggin structure [(PO4)@(V12O36)] capped by two [VO] units. PV14 (10 μM) exhibited higher ex-vivo inhibitory effect on Na+/K+-ATPase (78%) than was observed at the same concentrations of V10 (66%) or V1 (33%). Moreover, PV14 is also a potent in vitro inhibitor of the Ca2+-ATPase activity (IC50 5 μM) exhibiting stronger inhibition than the previously reported activities for V10 (15 μM) and V1 (80 μM). Putting it all together, when compared both P-typye ATPases it is suggested that PV14 exibited a high potential to act as an in vivo inhibitor of the Na+/K+-ATPase associated with chloride secretion.
id RCAP_c0b8ba92aee43a4320755370f50fa32c
oai_identifier_str oai:sapientia.ualg.pt:10400.1/12656
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadatePolyoxometalatesPhosphotetradecavanadateDecavanadateP-type ATPasesEpithelial chloride secretionPolyoxometalates (POMs) are promising inorganic inhibitors for P-type ATPases. The experimental models used to study the effects of POMs on these ATPases are usually in vitro models using vesicles from several membrane sources. Very recently, some polyoxotungstates, such as the Dawson anion [P2W18O62]6-, were shown to be potent P-type ATPase inhibitors; being active in vitro as well as in ex-vivo. In the present study we broaden the spectrum of highly active inhibitors of Na+/K+-ATPase from basal membrane of epithelial skin to the bi-capped Keggin-type anion phosphotetradecavanadate Cs5.6H3.4PV14O42 (PV14) and we confront the data with activity of other commonly encountered polyoxovanadates, decavanadate (V10) and monovanadate (V1). The X-ray crystal structure of PV14 was solved and contains two trans-bicapped α-Keggin anions HxPV14O42(9-x)-. The anion is built up from the classical Keggin structure [(PO4)@(V12O36)] capped by two [VO] units. PV14 (10 μM) exhibited higher ex-vivo inhibitory effect on Na+/K+-ATPase (78%) than was observed at the same concentrations of V10 (66%) or V1 (33%). Moreover, PV14 is also a potent in vitro inhibitor of the Ca2+-ATPase activity (IC50 5 μM) exhibiting stronger inhibition than the previously reported activities for V10 (15 μM) and V1 (80 μM). Putting it all together, when compared both P-typye ATPases it is suggested that PV14 exibited a high potential to act as an in vivo inhibitor of the Na+/K+-ATPase associated with chloride secretion.ElsevierSapientiaFraqueza, GilFuentes, JuanKrivosudský, LukášDutta, SaikatMal, Sib SankarRoller, AlexanderGiester, GeraldRompel, AnnetteAureliano, Manuel2019-07-12T12:53:12Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/12656eng0162-013410.1016/j.jinorgbio.2019.110700info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-18T17:20:54Zoai:sapientia.ualg.pt:10400.1/12656Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T20:19:12.428139Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate
title Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate
spellingShingle Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate
Fraqueza, Gil
Polyoxometalates
Phosphotetradecavanadate
Decavanadate
P-type ATPases
Epithelial chloride secretion
title_short Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate
title_full Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate
title_fullStr Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate
title_full_unstemmed Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate
title_sort Inhibition of Na+/K+- and Ca2+-ATPase activities by phosphotetradecavanadate
author Fraqueza, Gil
author_facet Fraqueza, Gil
Fuentes, Juan
Krivosudský, Lukáš
Dutta, Saikat
Mal, Sib Sankar
Roller, Alexander
Giester, Gerald
Rompel, Annette
Aureliano, Manuel
author_role author
author2 Fuentes, Juan
Krivosudský, Lukáš
Dutta, Saikat
Mal, Sib Sankar
Roller, Alexander
Giester, Gerald
Rompel, Annette
Aureliano, Manuel
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Fraqueza, Gil
Fuentes, Juan
Krivosudský, Lukáš
Dutta, Saikat
Mal, Sib Sankar
Roller, Alexander
Giester, Gerald
Rompel, Annette
Aureliano, Manuel
dc.subject.por.fl_str_mv Polyoxometalates
Phosphotetradecavanadate
Decavanadate
P-type ATPases
Epithelial chloride secretion
topic Polyoxometalates
Phosphotetradecavanadate
Decavanadate
P-type ATPases
Epithelial chloride secretion
description Polyoxometalates (POMs) are promising inorganic inhibitors for P-type ATPases. The experimental models used to study the effects of POMs on these ATPases are usually in vitro models using vesicles from several membrane sources. Very recently, some polyoxotungstates, such as the Dawson anion [P2W18O62]6-, were shown to be potent P-type ATPase inhibitors; being active in vitro as well as in ex-vivo. In the present study we broaden the spectrum of highly active inhibitors of Na+/K+-ATPase from basal membrane of epithelial skin to the bi-capped Keggin-type anion phosphotetradecavanadate Cs5.6H3.4PV14O42 (PV14) and we confront the data with activity of other commonly encountered polyoxovanadates, decavanadate (V10) and monovanadate (V1). The X-ray crystal structure of PV14 was solved and contains two trans-bicapped α-Keggin anions HxPV14O42(9-x)-. The anion is built up from the classical Keggin structure [(PO4)@(V12O36)] capped by two [VO] units. PV14 (10 μM) exhibited higher ex-vivo inhibitory effect on Na+/K+-ATPase (78%) than was observed at the same concentrations of V10 (66%) or V1 (33%). Moreover, PV14 is also a potent in vitro inhibitor of the Ca2+-ATPase activity (IC50 5 μM) exhibiting stronger inhibition than the previously reported activities for V10 (15 μM) and V1 (80 μM). Putting it all together, when compared both P-typye ATPases it is suggested that PV14 exibited a high potential to act as an in vivo inhibitor of the Na+/K+-ATPase associated with chloride secretion.
publishDate 2019
dc.date.none.fl_str_mv 2019-07-12T12:53:12Z
2019
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/12656
url http://hdl.handle.net/10400.1/12656
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0162-0134
10.1016/j.jinorgbio.2019.110700
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833598600471379968